DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 30 · March 1997 DOI: 10.1055/s-002-6362

Original Papers

35
Meyer-Lindenberg, A.; Gruppe, H.; Bauer, Ulrike; Lis, Stefanie; Krieger, S.; Gallhofer, B.: Improvement of Cognitive Function in Schizophrenic Patients Receiving Clozapine or Zotepine: Results from a Double-Blind Study
43
Baptista, T.; López, M. E.; Teneud, L.; Contreras, Q.; Alastre, T.; de Quijada, M.; de Baptista, E. Araujo; Alternus, M.; Weiss, S. R. B.; Musseo, E.; Páez, X.; Hernández, L.: Amantadine in the Treatment of Neuroleptic-Induced Obesity in Rats: Behavioral, Endocrine and Neurochemical Correlates
55
Maj, J.; Kołodziejczyk, K.; Rogóż, Z.; Skuza, G.: Roxindole, a Dopamine Autoreceptor Agonist with a Potential Antidepressant Activity
62
Adler, L.; Hajak, G.; Lehmann, K.; Kunert, H.-J.; Hoffmann, G.; Issinger, J.; Böke, J.; Huether, G.; Rüther, E.: On the Problems of Switching from Intravenous to Oral Administration in Drug Treatment of Endogenous Depression

Short Communication

70
Grassi, Barbara; Gambini, Orsola; Garghentini, G.; Lazzarin, A.; Scarone, S.: Efficacy of Paroxetine for the Treatment of Depression in the Context of HIV Infection

Case Report

72
Knoll, B.; Haefeli, W. E.; Ladewig, D.; Stohler, R.: Early Recurrence of Withdrawal Symptoms under Phenytoin and Chronic Alcohol Use